{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:11:39Z","timestamp":1789816299813,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19bm0804009"],"award-info":[{"award-number":["JP19bm0804009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22bm1123004"],"award-info":[{"award-number":["JP22bm1123004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H03619"],"award-info":[{"award-number":["JP19H03619"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K19448"],"award-info":[{"award-number":["JP21K19448"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H03039"],"award-info":[{"award-number":["JP22H03039"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K15709"],"award-info":[{"award-number":["JP18K15709"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project MEET, Osaka University Graduate School of Medicine Mitsubishi Tanabe Pharma Corporation"},{"name":"Korean Scholarship Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09902-6","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:46:17Z","timestamp":1774341977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interplay between DYRK1A dosage and aneuploidy-induced neuropathology in Down syndrome"],"prefix":"10.1038","volume":"9","author":[{"given":"Toshihiko","family":"Nambara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kawatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Kusakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2985-1338","authenticated-orcid":false,"given":"Hidetaka","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3148-9892","authenticated-orcid":false,"given":"Katsuya","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5110-1440","authenticated-orcid":false,"given":"Kazuto","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7543-7301","authenticated-orcid":false,"given":"Tomoji","family":"Mashimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tanave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8785-5439","authenticated-orcid":false,"given":"Kenta","family":"Sumiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6517-8825","authenticated-orcid":false,"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2907-9512","authenticated-orcid":false,"given":"Yasuji","family":"Kitabatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"9902_CR1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrg2538","volume":"10","author":"JM Vaquerizas","year":"2009","unstructured":"Vaquerizas, J. M., Kummerfeld, S. K., Teichmann, S. A. & Luscombe, N. M. A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet. 10, 252\u2013263 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"9902_CR2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neubiorev.2019.01.001","volume":"98","author":"RA Vacca","year":"2019","unstructured":"Vacca, R. A. et al. Down syndrome: neurobiological alterations and therapeutic targets. Neurosci. Biobehav. Rev. 98, 234\u2013255 (2019).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"9902_CR3","first-page":"109","volume":"49","author":"G Zdaniuk","year":"2011","unstructured":"Zdaniuk, G., Wierzba-Bobrowicz, T., Szpak, G. M. & Stepien, T. Astroglia disturbances during development of the central nervous system in fetuses with Down\u2019s syndrome. Folia Neuropathol. 49, 109\u2013114 (2011).","journal-title":"Folia Neuropathol."},{"key":"9902_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0197-4580(98)00074-8","volume":"19","author":"WS Griffin","year":"1998","unstructured":"Griffin, W. S. et al. Life-long overexpression of S100beta in Down\u2019s syndrome: implications for Alzheimer pathogenesis. Neurobiol. Aging 19, 401\u2013405 (1998).","journal-title":"Neurobiol. Aging"},{"key":"9902_CR5","volume":"16","author":"JA Klein","year":"2022","unstructured":"Klein, J. A. & Haydar, T. F. Neurodevelopment in Down syndrome: concordance in humans and models. Front. Cell. Neurosci. 16, 941855 (2022).","journal-title":"Front. Cell. Neurosci."},{"key":"9902_CR6","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.702685","volume":"15","author":"B Ponroy Bally","year":"2021","unstructured":"Ponroy Bally, B. & Murai, K. K. Astrocytes in Down syndrome across the lifespan. Front. Cell. Neurosci. 15, 702685 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"9902_CR7","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1093\/brain\/awaa326","volume":"143","author":"L Flores-Aguilar","year":"2020","unstructured":"Flores-Aguilar, L. et al. Evolution of neuroinflammation across the lifespan of individuals with Down syndrome. Brain 143, 3653\u20133671 (2020).","journal-title":"Brain"},{"key":"9902_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.1160058","volume":"322","author":"BR Williams","year":"2008","unstructured":"Williams, B. R. et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322, 703\u2013709 (2008).","journal-title":"Science"},{"key":"9902_CR9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1142210","volume":"317","author":"EM Torres","year":"2007","unstructured":"Torres, E. M. et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317, 916\u2013924 (2007).","journal-title":"Science"},{"key":"9902_CR10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.aaw5185","volume":"366","author":"PJ Zhu","year":"2019","unstructured":"Zhu, P. J. et al. Activation of the ISR mediates the behavioral and neurophysiological abnormalities in Down syndrome. Science 366, 843\u2013849 (2019).","journal-title":"Science"},{"key":"9902_CR11","doi-asserted-by":"crossref","first-page":"e0219592","DOI":"10.1371\/journal.pone.0219592","volume":"14","author":"N Nawa","year":"2019","unstructured":"Nawa, N. et al. Elimination of protein aggregates prevents premature senescence in human trisomy 21 fibroblasts. PLoS ONE 14, e0219592 (2019).","journal-title":"PLoS ONE"},{"key":"9902_CR12","volume":"10","author":"K Hirata","year":"2020","unstructured":"Hirata, K. et al. 4-phenylbutyrate ameliorates apoptotic neural cell death in Down syndrome by reducing protein aggregates. Sci. Rep. 10, 14047 (2020).","journal-title":"Sci. Rep."},{"key":"9902_CR13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-00714-7","volume":"7","author":"S Omori","year":"2017","unstructured":"Omori, S. et al. A pair of maternal chromosomes derived from meiotic nondisjunction in trisomy 21 affects nuclear architecture and transcriptional regulation. Sci. Rep. 7, 764 (2017).","journal-title":"Sci. Rep."},{"key":"9902_CR14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785\u2013798 (2013).","journal-title":"Neuron"},{"key":"9902_CR15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12013-010-9138-4","volume":"60","author":"D Shen","year":"2011","unstructured":"Shen, D. et al. Novel cell- and tissue-based assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies. Cell Biochem. Biophys. 60, 173\u2013185 (2011).","journal-title":"Cell Biochem. Biophys."},{"key":"9902_CR16","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.4103\/1673-5374.284977","volume":"15","author":"AD Foster","year":"2020","unstructured":"Foster, A. D. & Rea, S. L. The role of sequestosome 1\/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis. Neural Regen. Res. 15, 2186\u20132194 (2020).","journal-title":"Neural Regen. Res."},{"key":"9902_CR17","doi-asserted-by":"crossref","unstructured":"Gonzalez-Ortiz, F. et al. Plasma phospho-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications. Mol. Neurodegener. 18, 18 (2023).","DOI":"10.1186\/s13024-023-00605-8"},{"key":"9902_CR18","doi-asserted-by":"crossref","unstructured":"Lle\u00f3, A. et al. Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer\u2019s disease in adults with Down syndrome. Nat. Commun. 12, 4304 (2021).","DOI":"10.1038\/s41467-021-24319-x"},{"key":"9902_CR19","volume":"21","author":"ME Petersen","year":"2025","unstructured":"Petersen, M. E. et al. Blood biomarkers in Down syndrome: facilitating Alzheimer\u2019s disease detection and monitoring. Alzheimer\u2019s Dement. 21, e14364 (2025).","journal-title":"Alzheimer\u2019s Dement."},{"key":"9902_CR20","volume":"5","author":"C Chen","year":"2014","unstructured":"Chen, C. et al. Role of astroglia in Down\u2019s syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat. Commun. 5, 4430 (2014).","journal-title":"Nat. Commun."},{"key":"9902_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.5966\/sctm.2013-0153","volume":"3","author":"AM Haidet-Phillips","year":"2014","unstructured":"Haidet-Phillips, A. M. et al. Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment. Stem Cells Transl. Med. 3, 575\u2013585 (2014).","journal-title":"Stem Cells Transl. Med."},{"key":"9902_CR22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s42003-021-02242-7","volume":"4","author":"K Kawatani","year":"2021","unstructured":"Kawatani, K. et al. A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome. Commun. Biol. 4, 730 (2021).","journal-title":"Commun. Biol."},{"key":"9902_CR23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/JLB.3MR0720-513R","volume":"108","author":"CM McKee","year":"2020","unstructured":"McKee, C. M. & Coll, R. C. NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma. J. Leukoc. Biol. 108, 937\u2013952 (2020).","journal-title":"J. Leukoc. Biol."},{"key":"9902_CR24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s42003-020-0792-9","volume":"3","author":"C Hughes","year":"2020","unstructured":"Hughes, C. et al. Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death. Commun. Biol. 3, 79 (2020).","journal-title":"Commun. Biol."},{"key":"9902_CR25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.celrep.2016.04.031","volume":"15","author":"K Banno","year":"2016","unstructured":"Banno, K. et al. Systematic cellular disease models reveal synergistic interaction of trisomy 21 and GATA1 mutations in hematopoietic abnormalities. Cell Rep. 15, 1228\u20131241 (2016).","journal-title":"Cell Rep."},{"key":"9902_CR26","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1523\/JNEUROSCI.1709-08.2008","volume":"28","author":"JE Herrmann","year":"2008","unstructured":"Herrmann, J. E. et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28, 7231\u20137243 (2008).","journal-title":"J. Neurosci."},{"key":"9902_CR27","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.15252\/embr.201540374","volume":"16","author":"N Kurabayashi","year":"2015","unstructured":"Kurabayashi, N., Nguyen, M. D. & Sanada, K. DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model. EMBO Rep. 16, 1548\u20131562 (2015).","journal-title":"EMBO Rep."},{"key":"9902_CR28","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1084\/jem.20172158","volume":"215","author":"H Martini-Stoica","year":"2018","unstructured":"Martini-Stoica, H. et al. TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. J. Exp. Med. 215, 2355\u20132377 (2018).","journal-title":"J. Exp. Med."},{"key":"9902_CR29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fnins.2019.00649","volume":"13","author":"C Pernegre","year":"2019","unstructured":"Pernegre, C., Duquette, A. & Leclerc, N. Tau secretion: good and bad for neurons. Front. Neurosci. 13, 649 (2019).","journal-title":"Front. Neurosci."},{"key":"9902_CR30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler, A. M., Phillips, E. C., Lau, D. H., Noble, W. & Hanger, D. P. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 14, 389\u2013394 (2013).","journal-title":"EMBO Rep."},{"key":"9902_CR31","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.645233","volume":"15","author":"RM Fleeman","year":"2021","unstructured":"Fleeman, R. M. & Proctor, E. A. Astrocytic propagation of tau in the context of Alzheimer\u2019s disease. Front. Cell. Neurosci. 15, 645233 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"9902_CR32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41380-023-02333-3","volume":"29","author":"E Fertan","year":"2024","unstructured":"Fertan, E. et al. Cerebral organoids with chromosome 21 trisomy secrete Alzheimer\u2019s disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy. Mol. Psychiatry 29, 369\u2013386 (2024).","journal-title":"Mol. Psychiatry"},{"key":"9902_CR33","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1038\/s41380-020-0806-5","volume":"26","author":"I Ali\u0107","year":"2021","unstructured":"Ali\u0107, I. et al. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain. Mol. Psychiatry 26, 5766\u20135788 (2021).","journal-title":"Mol. Psychiatry"},{"key":"9902_CR34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Buee","year":"2000","unstructured":"Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. & Hof, P. R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33, 95\u2013130 (2000).","journal-title":"Brain Res. Rev."},{"key":"9902_CR35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuron.2018.04.035","volume":"98","author":"C Sato","year":"2018","unstructured":"Sato, C. et al. Tau kinetics in neurons and the human central nervous system. Neuron 98, 861\u2013864 (2018).","journal-title":"Neuron"},{"key":"9902_CR36","volume":"7","author":"X Yin","year":"2017","unstructured":"Yin, X. et al. Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice. Sci. Rep. 7, 619 (2017).","journal-title":"Sci. Rep."},{"key":"9902_CR37","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.718426","volume":"13","author":"MM Ahmed","year":"2021","unstructured":"Ahmed, M. M. et al. Innate immune system activation and neuroinflammation in Down syndrome and neurodegeneration: therapeutic targets or partners? Front. Aging Neurosci. 13, 718426 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"9902_CR38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin, C. et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 24, 312\u2013325 (2021).","journal-title":"Nat. Neurosci."},{"key":"9902_CR39","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/glia.24191","volume":"70","author":"O Lawal","year":"2022","unstructured":"Lawal, O., Ulloa Severino, F. P. & Eroglu, C. The role of astrocyte structural plasticity in regulating neural circuit function and behavior. Glia 70, 1467\u20131483 (2022).","journal-title":"Glia"},{"key":"9902_CR40","doi-asserted-by":"publisher","unstructured":"Ferrari-Souza, J. P. et al. Astrocyte biomarker signatures of amyloid-beta and tau pathologies in Alzheimer\u2019s disease. Mol Psychiatry https:\/\/doi.org\/10.1038\/s41380-022-01716-2 (2022).","DOI":"10.1038\/s41380-022-01716-2"},{"key":"9902_CR41","doi-asserted-by":"publisher","unstructured":"Brandebura, A. N., Paumier, A., Onur, T. S. & Allen, N. J. Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat. Rev. Neurosci. https:\/\/doi.org\/10.1038\/s41583-022-00641-1 (2022).","DOI":"10.1038\/s41583-022-00641-1"},{"key":"9902_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1742-4658.2010.07954.x","volume":"278","author":"FJ Tejedor","year":"2011","unstructured":"Tejedor, F. J. & Hammerle, B. MNB\/DYRK1A as a multiple regulator of neuronal development. FEBS J. 278, 223\u2013235 (2011).","journal-title":"FEBS J."},{"key":"9902_CR43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/geno.1999.5775","volume":"57","author":"J Guimera","year":"1999","unstructured":"Guimera, J., Casas, C., Estivill, X. & Pritchard, M. Human minibrain homologue (MNBH\/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 57, 407\u2013418 (1999).","journal-title":"Genomics"},{"key":"9902_CR44","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1073\/pnas.1704143114","volume":"114","author":"A Nakano-Kobayashi","year":"2017","unstructured":"Nakano-Kobayashi, A. et al. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice. Proc. Natl. Acad. Sci. USA. 114, 10268\u201310273 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9902_CR45","doi-asserted-by":"crossref","first-page":"e4606","DOI":"10.1371\/journal.pone.0004606","volume":"4","author":"F Guedj","year":"2009","unstructured":"Guedj, F. et al. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS ONE 4, e4606 (2009).","journal-title":"PLoS ONE"},{"key":"9902_CR46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","volume":"15","author":"R de la Torre","year":"2016","unstructured":"de la Torre, R. et al. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down\u2019s syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 15, 801\u2013810 (2016).","journal-title":"Lancet Neurol."},{"key":"9902_CR47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mnfr.201300325","volume":"58","author":"R De la Torre","year":"2014","unstructured":"De la Torre, R. et al. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol. Nutr. Food Res. 58, 278\u2013288 (2014).","journal-title":"Mol. Nutr. Food Res."},{"key":"9902_CR48","doi-asserted-by":"publisher","unstructured":"Atas-Ozcan, H., Brault, V., Duchon, A. & Herault, Y. Dyrk1a from gene function in development and physiology to dosage correction across life span in Down syndrome. Genes 12, https:\/\/doi.org\/10.3390\/genes12111833 (2021).","DOI":"10.3390\/genes12111833"},{"key":"9902_CR49","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","volume":"338","author":"BJ O\u2019Roak","year":"2012","unstructured":"O\u2019Roak, B. J. et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619\u20131622 (2012).","journal-title":"Science"},{"key":"9902_CR50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10989","volume":"485","author":"BJ O\u2019Roak","year":"2012","unstructured":"O\u2019Roak, B. J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246\u2013250 (2012).","journal-title":"Nature"},{"key":"9902_CR51","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1074\/jbc.M110.183780","volume":"286","author":"K Nishimura","year":"2011","unstructured":"Nishimura, K. et al. Development of defective and persistent Sendai virus vector: a unique gene delivery\/expression system ideal for cell reprogramming. J. Biol. Chem. 286, 4760\u20134771 (2011).","journal-title":"J. Biol. Chem."},{"key":"9902_CR52","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.stemcr.2017.06.018","volume":"9","author":"J Tcw","year":"2017","unstructured":"Tcw, J. et al. An efficient platform for astrocyte differentiation from human induced pluripotent stem cells. Stem Cell Rep. 9, 600\u2013614 (2017).","journal-title":"Stem Cell Rep."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09902-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:53:08Z","timestamp":1778853188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09902-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9902"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09902-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"660"}}